Global Sterile Injectable Drugs Market to Reach $1.3 Trillion by 2030
The global market for Sterile Injectable Drugs estimated at US$656.1 Billion in the year 2023, is expected to reach US$1.3 Trillion by 2030, growing at a CAGR of 9.7% over the period 2023-2030. Small Molecule Sterile Injectable Drugs, one of the segments analyzed in the report, is expected to record 9.4% CAGR and reach US$522.6 Billion by the end of the analysis period. Growth in the Large Molecule Sterile Injectable Drugs segment is estimated at 9.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $203.1 Billion, While China is Forecast to Grow at 9% CAGR
The Sterile Injectable Drugs market in the U.S. is estimated at US$203.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$213 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 7.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook